Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
11/27/2002
Lexicon Genetics Files Shelf Registration Statement
11/01/2002
Lexicon Genetics Discovers Target for Development of Drugs to Prevent Heart Attacks and Strokes
10/31/2002
Lexicon Genetics CEO to Present at the CIBC World Markets 13th Annual Healthcare Conference
10/30/2002
Lexicon Genetics Reports Third Quarter 2002 Financial Results
10/24/2002
Lexicon Genetics Renews and Expands Licenses for Gene Targeting Technology
10/17/2002
Webcast Alert: Lexicon Genetics to Hold Third Quarter 2002 Financial Results
10/04/2002
Lexicon Genetics Discovers New Role for Protein to Develop Antibody For Treatment of Inflammation
09/04/2002
Lexicon Genetics Advances New Target for Development of Drugs to Treat Obesity
08/21/2002
Lexicon Genetics Announces Issuance of Gene Trapping, Drug Target Patents
08/20/2002
Lexicon Genetics Appoints Brian P. Zambrowicz, Ph.D. Executive Vice President Of Research
«
Start
Prev
31
32
33
34
35
36
37
38
39
40
Next
End
»
Page 31 of 42
